SCHEMBL6089308

SCHEMBL6089308

COCNC(=O)c1cc2c(F)cccc2s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
HDAC3 O15379 2/20 0.52
HDAC4 P56524 2/20 0.52
HDAC1 Q13547 2/20 0.52
HDAC7 Q8WUI4 2/20 0.52
HDAC2 Q92769 2/20 0.52
HDAC10 Q969S8 2/20 0.52
HDAC11 Q96DB2 2/20 0.52
HDAC8 Q9BY41 2/20 0.52
HDAC6 Q9UBN7 2/20 0.52
HDAC9 Q9UKV0 2/20 0.52
HDAC5 Q9UQL6 2/20 0.52
SLC9A1 P19634 5/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 3/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721446 0.80 L3MBTL1 (0.57) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5315745 0.75 RAB9A (0.53) ALDH1A1RAB9ANPC1HTTPOLB
SCHEMBL6089271 0.75 SLC9A1 (0.60) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6331522 0.74 SLC9A1 (0.56) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL18264031 0.73 ALDH1A1 (0.54) L3MBTL1HDAC3HDAC4HDAC1HDAC6
SCHEMBL2893037 0.73 SLC9A1 (0.62) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6089315 0.72 CLK1 (0.53) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6337681 0.71 L3MBTL1 (0.57) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL828732 0.70 SLC9A1 (0.62) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL10980463 0.70 SLC9A1 (0.52) L3MBTL1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R L3MBTL1 4610/4885HDAC3 405/4885HDAC4 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.